---
figid: PMC4447524__nihms666383f1
figlink: /pmc/articles/PMC4447524/figure/F1/
number: F1
caption: Resistance to BCR-ABL1 tyrosine kinase inhibitors may take the form of (left)
  point or compound mutation-based, BCR-ABL1-dependent resistance or (middle) recruitment
  of alternative pathway signaling upon effective inhibition of BCR-ABL1. (right)
  A subset of patients achieving deep remissions on TKI therapy who elect to stop
  therapy subsequently demonstrate apparently durable treatment-free remission (TFR).
pmcid: PMC4447524
papertitle: 'Chronic Myeloid Leukemia: Advances in Understanding Disease Biology and
  Mechanisms of Resistance to Tyrosine Kinase Inhibitors.'
reftext: Christopher A. Eide, et al. Curr Hematol Malig Rep. ;10(2):158-166.
pmc_ranked_result_index: '27760'
pathway_score: 0.9276825
filename: nihms666383f1.jpg
figtitle: Resistance to BCR-ABL1 tyrosine kinase inhibitors may take the form of (left)
  point or compound mutation-based, BCR-ABL1-dependent resistance or (middle) recruitment
  of alternative pathway signaling upon effective inhibition of BCR-ABL1
year: ''
organisms:
- Homo sapiens
ndex: 6fd0763d-df03-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4447524__nihms666383f1.html
  '@type': Dataset
  description: Resistance to BCR-ABL1 tyrosine kinase inhibitors may take the form
    of (left) point or compound mutation-based, BCR-ABL1-dependent resistance or (middle)
    recruitment of alternative pathway signaling upon effective inhibition of BCR-ABL1.
    (right) A subset of patients achieving deep remissions on TKI therapy who elect
    to stop therapy subsequently demonstrate apparently durable treatment-free remission
    (TFR).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - BCR
  - AGRP
  - JAK2
  - PIK3R6
  - MAP2K1
  - PIK3CD
  - MAP2K2
  - CP
  - PIK3R4
  - POR
  - PIK3R3
  - STAT3
  - FGF2
  - MAP6
  - SRC
  - PIK3R5
  - PIK3CB
  - PIK3CG
  - H bosutinib
  - nilotinib
  - H ponatinib
  - ponatinib
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: CML
  symbol: CML
  source: hgnc_alias_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: art
  symbol: ART
  source: hgnc_alias_symbol
  hgnc_symbol: AGRP
  entrez: '181'
- word: JAK2|MEK
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: JAK2|MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: JAK2|MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CP
  symbol: CP
  source: hgnc_symbol
  hgnc_symbol: CP
  entrez: '1356'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: POR
  symbol: POR
  source: hgnc_symbol
  hgnc_symbol: POR
  entrez: '5447'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: Stop
  symbol: STOP
  source: hgnc_alias_symbol
  hgnc_symbol: MAP6
  entrez: '4135'
- word: SRC|FGF2
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals:
- word: H bosutinib
  source: MESH
  identifier: C471992
- word: nilotinib
  source: MESH
  identifier: C498826
- word: H ponatinib
  source: MESH
  identifier: C545373
- word: ponatinib
  source: MESH
  identifier: C545373
diseases: []
figid_alias: PMC4447524__F1
redirect_from: /figures/PMC4447524__F1
figtype: Figure
---
